[6] Of his decision to pursue a career as a chemist, Hofmann provided insight during a speech he delivered to the 1996 Worlds of Consciousness Conference in Heidelberg, Germany: One often asks oneself what roles planning and chance play in the realization of the most important events in our lives.
Mystical experiences in childhood, in which Nature was altered in magical ways, had provoked questions concerning the essence of the external, material world, and chemistry was the scientific field which might afford insights into this.
[8] He began studying the medicinal plant Drimia maritima (squill) and the fungus ergot as part of a program to purify and synthesize active constituents for use as pharmaceuticals.
[9] The main intention of the synthesis was to obtain a respiratory and circulatory stimulant (analeptic) with no effects on the uterus in analogy to nikethamide (which is also a diethylamide) by introducing this functional group to lysergic acid.
In a dreamlike state, with eyes closed (I found the daylight to be unpleasantly glaring), I perceived an uninterrupted stream of fantastic pictures, extraordinary shapes with intense, kaleidoscopic play of colors.
[11]Three days later, on 19 April 1943, Hofmann intentionally ingested 250 micrograms of LSD, which he thought would represent a prudently safe, small amount, but was in fact a strong dose.
At first, his trip was not pleasant, as people appeared to morph into fantastic creatures, office furniture moved and shifted like living entities, and he felt possessed by otherworldly forces.
April 19 is now widely known as "Bicycle Day", because as Hofmann began to feel LSD's effects, he tried to ride to the safety of his home on his bike.
In his memoir, he emphasized it as a "sacred drug": "I see the true importance of LSD in the possibility of providing material aid to meditation aimed at the mystical experience of a deeper, comprehensive reality.
Hofmann became director of Sandoz's natural products department and continued studying hallucinogenic substances found in Mexican mushrooms and other plants used by aboriginal people there.
He conceded that it could be dangerous if misused, because a relatively high dose of 500 micrograms has an extremely powerful psychoactive effect, especially if administered to a first-time user without adequate supervision.
[17] In December 2007, Swiss medical authorities allowed psychotherapist Peter Gasser to perform psychotherapeutic experiments on patients with terminal-stage cancer and other terminal diseases.
[25] The Swiss Federal Institute of Technology (ETH Zurich) honored him with the title DSc (honoris causa) in 1969 together with Gustav Guanella, his brother-in-law.